Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940.SZ)

CNY 13.82

(-0.22%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 3.01 Billion 2.59 Billion 2.08 Billion 1.94 Billion 1.38 Billion 1.47 Billion
Total Current Assets 1.56 Billion 1.45 Billion 1.37 Billion 1.39 Billion 977.66 Million 1.07 Billion
Cash And Short Term Investments 869.74 Million 804.76 Million 748.5 Million 854.06 Million 627.75 Million 618.33 Million
Cash and Cash Equivalents 859.74 Million 735.46 Million 688.9 Million 854.06 Million 527.69 Million 618.33 Million
Short Term Investments 10 Million 69.29 Million 59.6 Million -1.53 Million 100.05 Million 55.07 Million
Net Receivables 275.37 Million 344.25 Million 312.13 Million 264.87 Million 203.83 Million 285.89 Million
Inventory 393.44 Million 293.22 Million 299.6 Million 262.99 Million 139 Million 171.8 Million
Other Current Assets 23.36 Million 9.7 Million 15.7 Million 11.45 Million 7.07 Million 3.95 Million
Total Non-Current Assets 1.45 Billion 1.14 Billion 707.62 Million 547.35 Million 407.32 Million 390.21 Million
Net PPE 615.79 Million 445.7 Million 474.63 Million 389.5 Million 304.58 Million 272.53 Million
Good Will And Intangible Assets 481.08 Million 60.75 Million 62.03 Million 36.88 Million 38.86 Million 40.15 Million
Good Will 312.94 Million 21.97 Million 21.97 Million - - -
Intangible Assets 168.13 Million 38.77 Million 40.05 Million 36.88 Million 38.86 Million 40.15 Million
Long-Term Investments 291.4 Million 232.85 Million 87.74 Million 96.52 Million -56.4 Million 1.00
Tax Assets 32.77 Million 22.44 Million 20.65 Million 22.87 Million 17.26 Million 20.25 Million
Other Non Current Assets 37 Million 382.37 Million 62.56 Million 1.56 Million 103.02 Million 57.27 Million
Other Assets - 1.00 - - 1.00 -
Total Liabilities 1.18 Billion 949.92 Million 608.64 Million 562.78 Million 368.51 Million 499.27 Million
Total Current Liabilities 731.97 Million 788.58 Million 595.28 Million 545.19 Million 355.17 Million 486.36 Million
Account Payables 402.48 Million 320.45 Million 335.97 Million 322.73 Million 144.32 Million 240.12 Million
Tax Payables 14.95 Million 35.52 Million 29.29 Million 22.3 Million 14.79 Million 24.95 Million
Short Term Debt 163.8 Million 195.2 Million 98.13 Million 10 Million 69.83 Million 15 Million
Deferred Revenue 164.31 Million 33.06 Million 23.29 Million 211.27 Million 17.05 Million 24.95 Million
Other Current Liabilities 1.36 Million 239.86 Million 137.88 Million 1.17 Million 123.96 Million 206.28 Million
Total Non Current Liabilities 455.74 Million 161.33 Million 13.35 Million 17.59 Million 13.34 Million 12.9 Million
Long-Term Debt 423.95 Million 150 Million - - - -
Deferred Revenue Non Current 17.84 Million 9.73 Million 13.3 Million 17.59 Million 13.34 Million 12.9 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities - - - - - -
Other Liabilities - 1.00 1.00 - - 1.00
Total Equity 1.83 Billion 1.64 Billion 1.47 Billion 1.37 Billion 1.01 Billion 970.92 Million
Stock Holders Equity 1.58 Billion 1.5 Billion 1.33 Billion 1.31 Billion 965.12 Million 919.06 Million
Common Stock 201.72 Million 139.12 Million 95.94 Million 95.94 Million 90 Million 90 Million
Retained Earnings 605.93 Million 519.67 Million 432.37 Million 359.47 Million 288.72 Million 247.91 Million
Accumulated other comprehensive income 105.17 Million 91.82 Million 78.64 Million 68.22 Million 52.55 Million 86.73 Million
Common Stock Equity 1.58 Billion 1.5 Billion 1.33 Billion 1.31 Billion 965.12 Million 919.06 Million
Capital Lease Obligation - - - - - -
Total Investments 301.4 Million 302.14 Million 147.34 Million 94.98 Million 43.64 Million 55.07 Million
Total Debt 587.75 Million 345.2 Million 98.13 Million 10 Million 69.83 Million 15 Million
Net Debt -271.99 Million -390.26 Million -590.77 Million -844.05 Million -457.86 Million -603.33 Million

Balance Sheet Charts